Capture compound mass spectrometry: a technology for the investigation of small molecule protein interactions.
One of the major hurdles in the post-genomic era is to understand the function of genes and the interplay of many different cellular proteins. This is especially important for drug development. Capture compound mass spectrometry (CCMS) addresses this challenge by selectively reducing the complexity of the proteome. Capture compounds are trifunctional molecules: a selectivity function reversibly interacts via affinity with proteins; a reactivity function irreversibly forms a covalent bond outside the affinity binding site; and a sorting/pullout function allows the captured protein(s) to be isolated from cellular lysate for mass spectrometric analysis and characterization by database queries. In the present study, we demonstrate the use of a CCMS capture compound with a sulfonamide drug analog as its selectivity function, isolating an expected target protein from cell lysates containing a large excess of other "non-target" proteins. A future application of CCMS is to define or confirm drug target proteins and their mechanisms of drug action, or to discover off-target proteins that cause side effects, enabling subsequent drug structure optimization.
Köster
Hubert
H
Caprotec GmbH, Berlin, Germany. hubert.koester@caprotec.com
Little
Daniel P
DP
Luan
Peng
P
Muller
Rolf
R
Siddiqi
Suhaib M
SM
Marappan
Subramanian
S
Yip
Ping
P
D015195:Drug Design; D011485:Protein Binding; D011506:Proteins / Q000032:analysis*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / Q000379:methods*; D013449:Sulfonamides / Q000378:metabolism / Q000494:pharmacology
D011506:Proteins; D013449:Sulfonamides